Phathom Pharmaceuticals, Inc. (PHAT)
12.14
-0.53
(-4.18%)
USD |
NASDAQ |
May 07, 10:43
Phathom Pharmaceuticals Cash from Investing (Quarterly) : -0.061M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Replimune Group, Inc. | 75.12M |
| ANI Pharmaceuticals, Inc. | -1.403M |
| MannKind Corp. | -291.96M |
| Ocugen, Inc. | -- |
| Ligand Pharmaceuticals, Inc. | -18.10M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.65M |
| Cash from Financing (Quarterly) | 66.64M |
| Free Cash Flow | -97.76M |
| Free Cash Flow Per Share (Quarterly) | -0.1914 |
| Free Cash Flow to Equity (Quarterly) | 26.25M |
| Free Cash Flow to Firm (Quarterly) | 0.089M |
| Free Cash Flow Yield | -10.68% |